DIRS.INFO The most relevant business & tech news

WASHINGTON — President Joe Biden will name Jeff Zients to serve as his next chief of staff, replacing Ron Klain who is expected to leave in the coming weeks, an administration official and a person familiar with the matter told NBC News. Zients, who previously led the Biden administration’s Covid-19 response, left the administration briefly last April, but returned in the fall just before the midterm elections. News of Zients' selection was first reported by The Washington Post. Klain, who has served in the top role for more than two years, is expected to depart the Biden administration after the president's State of the Union address early next month, according to two sources familiar with the decision. Check back later for updates.

☆ Biden to name Jeff Zients as next chief of staff, source says
▼ + stars: | 2023-01-22 | by ( Nandita Bose | Jason Lange | ) www.reuters.com time to read: +2 min

WASHINGTON (Reuters) -U.S. President Joe Biden will name former COVID policy coordinator Jeff Zients as his next chief of staff, a source familiar with the matter said on Sunday, refreshing a key role as Biden readies a likely re-election bid and faces a probe of his handling of classified documents. FILE PHOTO: White House COVID-19 Response Coordinator Jeff Zients delivers remarks during a press briefing at the White House in Washington, U.S., April 13, 2021. REUTERS/Tom Brenner/File PhotoRon Klain, Biden’s current chief of staff, plans to leave his post in the coming weeks, sources familiar with the matter have told Reuters. Zients also served as an economic adviser to President Barack Obama’s administration, in which Biden served as vice president. The chief of staff position, considered one of the most important at the White House, is the senior political appointee responsible for driving the president’s policy agenda and ensuring appropriate staff members are hired.

☆ Biden will tap former COVID-19 response coordinator Jeff Zients as his next White House chief of staff, succeeding Ron Klain: report
▼ + stars: | 2023-01-22 | by ( John L. Dorman | ) www.businessinsider.com time to read: +2 min

President Biden has tapped Jeff Zients to be his next chief of staff, per The Washington Post. Zients would replace Ron Klain, a longtime aide who has been chief of staff since January 2021. A former White House counselor, Zients led the administration's coronavirus response efforts. Zients — a one-time White House counselor — oversaw the administration's COVID-19 response efforts, which included the massive push to vaccinate millions of Americans across the country. He then came onboard at the start of the Biden administration in January 2021, serving as both a counselor and the coronavirus response coordinator until April 2022.Insider reached out to the White House for comment.

☆ Jeff Zients reportedly will be Biden’s next chief of staff
▼ + stars: | 2023-01-22 | by ( Ashley Capoot | ) www.cnbc.com time to read: +1 min

Jeff Zients, the White House's Covid-19 response czar, speaks during a press briefing at the White House where they spoke about a pause in issuing the Johnson & Johnson Janssen Covid-19 vaccine on April 13, 2021, in Washington, DC. Jeff Zients will serve as President Joe Biden's next chief of staff, according to media reports on Sunday. After the midterm elections in November and an action-packed two years in the White House, Klain has told colleagues that he is ready for something different, a Washington Post report said. Klain previously acted as Biden's chief of staff during former President Barack Obama's first term, and he's worked with Biden since he ran for president back in 1987. A White House representative did not immediately respond to CNBC requests for comment.

[1/2] Ron Klain attends a meeting at the Oval Office of the White House in Washington October 22, 2014. REUTERS/Kevin Lamarque/File PhotoREHOBOTH BEACH, De., Jan 21 (Reuters) - Ron Klain, President Joe Biden's White House chief of staff, plans to leave his post in the coming weeks, sources familiar with the matter said on Saturday, a major changing of the guard. Klain, 61, has a long history at the White House, having served as chief of staff to former Vice President Al Gore and to Biden when he was vice president under President Barack Obama. The chief of staff position is one of the most important at the White House, the senior political appointee responsible for driving the president's policy agenda and ensuring appropriate staff members are hired. Biden's predecessor, Republican Donald Trump, burned through four chiefs of staff in four years including his first, Reince Priebus, who lasted 192 days.

☆ Ivanka Trump and Jared Kushner knew the 2020 election wasn't stolen and began to distance themselves before the results were even called, a new book says
▼ + stars: | 2022-09-28 | by ( Peter Baker | Susan Glasser | ) www.businessinsider.com time to read: +17 min

In their new book, journalists, Peter Baker and Susan Glasser go behind the scenes of the Trump White House. As the 2020 election results came in, Jared Kushner and Ivanka Trump had already moved on, the book says. They had their own future to think about, one that would no longer involve the White House. While still in the White House, he began writing a memoir focused on Middle East peacemaking. "We either have a vote WE control and WEwin OR it gets kicked to Congress 6 January 2021," Don Jr. wrote.

☆ Johnson&Johnson amână distribuirea vaccinului său în Europa, după întreruperea administrării acestuia în SUA
▼ + stars: | 2021-04-14 | by ( Publika.Md - Aici Sunt Știrile | ) www.publika.md time to read: +2 min

Grupul farmaceutic american Johnson & Johnson a anunţat marţi că a luat decizia să amâne începerea distribuirii vaccinului său anti-COVID-19 în Europa, după ce autorităţile sanitare americane au recomandat ''o pauză'' în administrarea acestui vaccin, pentru a fi investigate şase cazuri rare de tulburări de coagulare a sângelui semnalate în SUA, relatează AFP şi Reuters.Vaccinul Johnson & Johnson, administrat în doză unică, a fost autorizat de Agenţia Europeană a Medicamentului (EMA), dar încă nu a fost utilizat în Uniunea Europeană, scrie agerpres.ro În SUA au fost administrate până în prezent peste 6,8 milioane de doze din acest vaccin, dar agenţiile sanitare americane au cerut marţi suspendarea utilizării acestui ser după semnalarea a 6 cazuri de tromboze la femei cu vârste între 18 şi 48 de ani, dintre care una decedat, iar alta a fost internată în stare critică.În toate aceste cazuri este vorba despre un tip de cheag sanguin denumit ''tromboza sinusului venos cerebral'' (CVST ) şi asociat cu niveluri reduse ale trombocitelor.Responsabilul preşedinţiei americane însărcinat cu gestionarea crizei sanitare, Jeff Zients, a apreciat că întreruperea administrării vaccinului Johnson & Johnson, ca măsură de ''precauţie extremă'', nu va avea un impact semnificativ asupra campaniei de vaccinare anti-COVID-19 în SUA, întrucât acest ser reprezintă mai puţin de 5% din totalul dozelor folosite în această ţară.Centrul pentru Controlul şi Prevenirea Bolilor (CDC) şi Adminstraţia pentru Alimente şi Medicamente (FDA) au emis o declaraţie comună în care menţionează că astfel de efecte adverse par să fie extrem de rare în prezent şi nu a fost stabilită o relaţie de cauzalitate între vaccin şi formarea de cheaguri sangvine. Cele două instituţii americane se vor reuni miercuri pentru a analiza cazurile semnalate.Agenţia Europeană a Medicamentului (EMA) a anunţat săptămâna trecută că examinează patru cazuri rare de formare a unor cheaguri sangvine la persoane vaccinate cu vaccinul Johnson & Johnson în SUA, la fel cum a procedat pentru cazurile asemănătoare semnalate după vaccinare cu serul produs de AstraZeneca-Oxford.

Persons: Johnson, Jeff Zients Organizations: Johnson, Uniunea Europeană Locations: Europa, SUA, Oxford

Grupul farmaceutic american Johnson & Johnson a anunţat marţi că a luat decizia să amâne începerea distribuirii vaccinului său anti-Covid-19 în Europa, după ce autorităţile sanitare americane au recomandat „o pauză” în administrarea acestui vaccin, pentru a fi investigate şase cazuri rare de tulburări de coagulare a sângelui semnalate în SUA, relatează AFP şi Reuters. Vaccinul Johnson & Johnson, administrat în doză unică, a fost autorizat de Agenţia Europeană a Medicamentului (EMA), dar încă nu a fost utilizat în Uniunea Europeană. În toate aceste cazuri este vorba despre un tip de cheag sanguin denumit „tromboza sinusului venos cerebral” (CVST ) şi asociat cu niveluri reduse ale trombocitelor. Cele două instituţii americane se vor reuni miercuri pentru a analiza cazurile semnalate. Agenţia Europeană a Medicamentului (EMA) a anunţat săptămâna trecută că examinează patru cazuri rare de formare a unor cheaguri sangvine la persoane vaccinate cu vaccinul Johnson & Johnson în SUA, la fel cum a procedat pentru cazurile asemănătoare semnalate după vaccinare cu serul produs de AstraZeneca-Oxford.

Persons: Johnson, Reuters, Jeff Zients Organizations: Johnson, Uniunea Europeană Locations: Europa, SUA, Oxford

Search resuls for: "Zients"

9 mentions found